Combination of deferasirox and deferoxamine in management of iron overload in myelodysplastic syndromes (MDS): An update in a hepatopatic patient

被引：0
|
作者：
Cerchione, C. [1 ]
Cerciello, G. [1 ]
Della Pepa, R. [1 ]
Pugliese, N. [1 ]
Marano, L. [1 ]
Vitagliano, O. [1 ]
Matarazzo, M. [2 ]
Pane, F. [1 ]
Alfinito, F. [1 ]
机构：
[1] Univ Naples Federico II, Hematol, Naples, Italy
[2] Univ Naples Federico II, Clincal Med, Naples, Italy
来源：
LEUKEMIA RESEARCH | 2013年 / 37卷
关键词：
D O I：
10.1016/S0145-2126(13)70235-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-187
引用
收藏
页码：S108 / S108
页数：1
相关论文
共 50 条
  • [31] A 1-year randomized trial of deferasirox alone versus deferasirox and deferoxamine combination for the treatment of iron overload in thalassemia major
    Eghbali, Aziz
    Shokri, Pooria
    Afzal, Roghayeh Rahimi
    Bagheri, Bahador
    TRANSFUSION AND APHERESIS SCIENCE, 2019, 58 (04) : 429 - 433
  • [32] Deferasirox for managing iron overload in people with myelodysplastic syndrome
    Meerpohl, Joerg J.
    Schell, Lisa K.
    Ruecker, Gerta
    Fleeman, Nigel
    Motschall, Edith
    Niemeyer, Charlotte M.
    Bassler, Dirk
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (10):
  • [33] Deferasirox for managing iron overload in people with myelodysplastic syndrome
    Meerpohl, Joerg J.
    Antes, Gerd
    Ruecker, Gerta
    Fleeman, Nigel
    Motschall, Edith
    Niemeyer, Charlotte M.
    Bassler, Dirk
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (11):
  • [34] Desensitization to Deferasirox in a Patient with Iron Overload
    Bruner, Karen E.
    White, Kevin M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB119 - AB119
  • [35] Iron overload in myelodysplastic syndromes: Evidence based guidelines from the Canadian consortium on MDS
    Leitch, Heather A.
    Buckstein, Rena
    Zhu, Nancy
    Nevill, Thomas J.
    Yee, Karen W. L.
    Leber, Brian
    Keating, Mary-Margaret
    St Hilaire, Eve
    Kumar, Rajat
    Delage, Robert
    Geddes, Michelle
    Storring, John M.
    Shamy, April
    Elemary, Mohamed
    Wells, Richard A.
    LEUKEMIA RESEARCH, 2018, 74 : 21 - 41
  • [36] Disparities in criteria for initiating chelation therapy for iron overload in patients with myelodysplastic syndromes (MDS).
    Bennett, JM
    List, AF
    BLOOD, 2005, 106 (11) : 712A - 712A
  • [37] Myelodysplastic syndromes and the role of iron overload
    Harvey, R. Donald
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (07) : S3 - S9
  • [38] Iron overload in myelodysplastic syndromes Introduction
    Harvey, R. Donald
    Fausel, Christopher A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (07) : S2 - S2
  • [39] Iron overload in patients with myelodysplastic syndromes
    Jensen P.-D.
    Current Hematologic Malignancy Reports, 2007, 2 (1) : 13 - 21
  • [40] Impact of iron overload in myelodysplastic syndromes
    Fenaux, Pierre
    Rose, Christian
    BLOOD REVIEWS, 2009, 23 : S15 - S19
12345